DUBLIN–(BUSINESS WIRE)–The “Toll-Like
Receptor Modulators -Pipeline Insight, 2019” drug pipelines has
been added to ResearchAndMarkets.com’s offering.
Toll-Like Receptor Modulators – Pipeline Insight, 2019 report offers
comprehensive insights of the pipeline (under development) therapeutics
scenario and growth prospects across Toll-Like Receptor Modulators
development. The report provides detailed coverage of the pipeline
landscape for this mechanism of action, equipped with data from multiple
sources with complete pipeline analysis by developmental stage,
associated indications, route of administration and molecule type.
Descriptive coverage of pipeline development activities for Toll-Like
Receptor Modulators – Pipeline therapeutics development coverage
provides descriptive product profiles including (but not limited to)
drug description, product development and R&D activities encompassing
clinical and pre-clinical studies, designations, collaborations,
licensing deals, grants, technologies and patent details.
The report assesses the active Toll-Like Receptor Modulators pipeline
products by developmental stage, product type, molecule type, and
administration route.
Scope of the report
-
Provides a snapshot of the therapeutics pipeline activity for
Toll-Like Receptor Modulators -
Features the Toll-Like Receptor Modulators pipeline across the
complete product development cycle including all clinical and
non-clinical stages -
Offers detailed therapeutic product profiles of Toll-Like Receptor
Modulators with key coverage of developmental activities including
licensing & collaboration deals, patent details, designations,
technologies, indications and chemical information -
Therapeutic assessment of the active pipeline products by stage,
product type, molecule type, and route of administration -
Coverage of dormant and discontinued pipeline projects across
Toll-Like Receptor Modulators
Key Topics Covered:
1. Report Introduction
2. Toll-Like Receptor Modulators – Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Toll-Like Receptor Modulators
4. Comparative Analysis
5. Toll-Like Receptor Modulators Pipeline Products in Clinical
Stages
- Product Description
- Research and Development
- Product Development Activities
6. Toll-Like Receptor Modulators Pipeline Products in
Non-clinical Stages
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment: Active Products
- Pipeline Assessment by Route of Administration
- Pipeline Assessment by Stage and Route of Administration
- Pipeline Assessment by Molecule Type
- Pipeline Assessment by Stage and Molecule Type
8. Inactive Pipeline Products
- Product Description
- Research and Development
- Product Development Activities
- Reason for dormancy/discontinuation
Companies Mentioned
- 3M Drug Delivery Services
- Allergy Therapeutics
- AstraZeneca
- Bellicum Pharmaceuticals
- Cytos Biotechnology
- Dynavax Technologies
- European Pharma Company
- GlaxoSmithKline
- Hemispherx
- Index Pharmaceuticals
- Innate Pharma
- Jenken Biosciences
- Juvaris Biotherapeutics
- LigoCyte Pharmaceuticals
- Meda
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/nbootb
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Immune
Disorders Drugs